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Abstract
Background: The nosological assignment of congenital ocular motor apraxia type Cogan (COMA) is still
controversial. While regarded as a distinct entity by some authorities including the Online Mendelian Inheritance in
Man catalog of genetic disorders, others consider COMA merely a clinical symptom.
Methods: We performed a retrospective multicenter data collection study with re-evaluation of clinical and
neuroimaging data of 21 previously unreported patients (8 female, 13 male, ages ranging from 2 to 24 years)
diagnosed as having COMA.
Results: Ocular motor apraxia (OMA) was recognized during the first year of life and confined to horizontal pursuit
in all patients. OMA attenuated over the years in most cases, regressed completely in two siblings, and persisted
unimproved in one individual. Accompanying clinical features included early onset ataxia in most patients and
cognitive impairment with learning disability (n = 6) or intellectual disability (n = 4). Re-evaluation of MRI data sets
revealed a hitherto unrecognized molar tooth sign diagnostic for Joubert syndrome in 11 patients, neuroimaging
features of Poretti-Boltshauser syndrome in one case and cerebral malformation suspicious of a tubulinopathy in
another subject. In the remainder, MRI showed vermian hypo-/dysplasia in 4 and no abnormalities in another 4
patients. There was a strong trend to more severe cognitive impairment in patients with Joubert syndrome
compared to those with inconclusive MRI, but otherwise no significant difference in clinical phenotypes between
these two groups.
Conclusions: Systematical renewed analysis of neuroimaging data resulted in a diagnostic reappraisal in the
majority of patients with early-onset OMA in the cohort reported here. This finding poses a further challenge to the
notion of COMA constituting a separate entity and underlines the need for an expert assessment of neuroimaging
in children with COMA, especially if they show cognitive impairment.
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Background
The term congenital ocular motor apraxia (COMA) was
introduced by Cogan in 1952 when he described a par-
ticular disorder of voluntary horizontal gaze in four chil-
dren [1]. “Inability to turn the eyes voluntarily in a
direction for which there is full involuntary … control”
together with compensatory, jerky head movements con-
stituted the clinical hallmark of this condition. COMA is
related to the inability to initiate saccades.
During subsequent decades a wide range of disorders
associated with ocular motor apraxia (OMA) was recog-
nized [2]. However, several reviews and case reports of
congenital OMA, alternatively called “infantile-onset
saccade initiation delay”, stressed frequent consistent co-
occurrence with early-onset cerebellar ataxia and global
developmental delay [3–9]. Typically, OMA and ataxia
resolve over the years, while cognitive impairment per-
sists to variable degree [4, 7–9]. Thus, while OMA con-
stitutes a symptom, not a diagnosis [2], a concept of
COMA emerged indicating that this condition frames a
clinical entity and a genetic disorder with autosomal re-
cessive inheritance. The Online Mendelian Inheritance
in Man (OMIM) catalog of human genes and genetic
disorders provides a separate coding number (%257550)
for COMA. However, no gene associated with isolated
COMA has been identified yet.
On the other hand, early-onset OMA is a frequent
symptom of Joubert syndrome (JBTS), accompanied by
infantile muscular hypotonia, early-onset ataxia, neo-
natal breathing abnormalities with episodic tachypnea
and apnea, as well as developmental delay/intellectual
disability [10–12]. Thus there is considerable phenotypic
overlap of COMA and JBTS. Yet, both conditions are
separated on the basis of neuroimaging characteristics.
MRI in COMA was reported to be either normal or
show a vermian hypoplasia, preferentially of the inferior
portion of the vermis [13, 14]. A recent review of studies
performed between 1952 and 2012 included 91 patients
with a clinical phenotype consistent with COMA and
found MRI to be allegedly normal in 55 of them [15].
In contrast, a highly characteristic neuroimaging fea-
ture of JBTS in axial MRI of the brainstem was recog-
nized in 1997 and designated the “molar tooth sign”
(MTS) [16]. The “molar tooth” derives from the combin-
ation of elongated, thickened and horizontalised superior
cerebellar peduncles; hypo-/dysplasia of the cerebellar
vermis; and an abnormally deep interpeduncular fossa
at the section of the brainstem isthmus and upper
pons [12]. It is now considered to be pathognomonic
for JBTS [17].
Our study presented here originally aimed at identifi-
cation of the gene associated with COMA. However, re-
evaluation of clinical and neuroimaging data of patients
recruited with the diagnosis of COMA indicated that
delineation of COMA versus JBTS and clarification of the
nosological relationship between these two conditions are
mandatory and a prerequisite for genetic investigations in
COMA.
Methods
This study was approved by the ethics committee of the
Faculty of Medicine, University of Göttingen (file no. 19/
5/14). Written informed consent was obtained from all
families.
Patient cohort
Patients diagnosed as having COMA were collected (i)
from the cohort of patients of the Department of
Pediatric Neurology, University Medical Center Göttingen
(n = 4) and (ii) using an email based acquisition of rare
neurological disorders in childhood (“Erhebung Seltener
Neurologischer Erkrankungen im Kindesalter, ESNEK”)
[18] from pediatric neurologists in Germany (n = 16) and
Switzerland (n = 1).
Inclusion criteria for the definite COMA cohort com-
prised written informed consent of the parents or the
patient or both, early-onset OMA (diagnostic recogni-
tion within the first year of life), and availability of an
MRI in technical quality adequate for assessment of es-
pecially brainstem and cerebellum. We did not include
patients with the MTS already recognized on MRI, thus
with a preexisting diagnosis of JBTS.
Clinical and qualitative neuroimaging analysis
Demographic data, neurological features and informa-
tion about the developmental stage were compiled by re-
view of the clinical histories and by clinical-neurological
follow-up investigations. Information about ophthalmo-
logical features was collected from neuro-ophthalmological
or pediatric-neurological reports. Cognitive function was
assessed using standardized neuropsychological tests
whenever possible. Otherwise, the stage of mental develop-
mental was appraised from the patient’s history, clinical
examination, and reports from nursery or school. Add-
itional data were collected in an interview with the parents
conducted by telephone using a standardized questionnaire
(Additional file 1).
A comparison concerning qualitative neurological fea-
tures and quantifiable developmental data of the patient
subgroups with MTS on MRI vs. inconclusive MRI was
performed using T-test for independent variables and
Fisher´s exact test.
All MRI data sets were analyzed independently by two
pediatric neurologists with experience in neuroimaging
of the brainstem and cerebellum (EB, KB) [19]. All avail-
able imaging sequences in axial, coronal and sagittal
orientation were scrutinized with focus on size and pos-
ition of the superior cerebellar peduncles, hypo-/dysplasia
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of the cerebellar vermis, cerebellar cysts, brainstem
morphology including shape of the interpeduncular fossa
at the section of the brainstem isthmus and upper pons,
size and shape of the 4th ventricle, and any other cerebel-
lar or cerebral malformations.
Results
A total of 28 patients were recruited via email based ac-
quisition and from our own department. Among these,
critical reappraisal of disease course and clinical features
revealed that phenotypes were not consistent with
COMA in three cases (e.g., onset of OMA later than 2nd
birthday, neuroophthalmological features not consistent
with OMA). In additional three patients cranial MRI
was not available in sufficient technical quality. One pa-
tient already had a molecular genetic diagnosis of JBTS.
Thus 21 patients were included in this study (13 male, 8
female, two pairs of siblings, mean age 10 years
3 months, age range 2 years 8 months - 24 years). Paren-
tal consanguinity was reported in one patient (#7).
Table 1 summarizes clinical and neuroimaging features
of all 21 patients. The period during which COMA was
diagnosed in these patients spans from 1992 to 2013.
Ophthalmological features
In all patients OMA was recognized by attending physi-
cians during the child´s first year of life. Most children
(15 of 21 cases) presented with visual problems already
in the first months of life, before OMA was definitely di-
agnosed, occasionally giving rise to the concern of severe
visual impairment or even blindness. Initial visual symp-
toms included lack of fixation and visual pursuit (n =
12), nystagmus (n = 5), head tilting (n = 3), and strabism
(n = 2), with ages at onset ranging from 4 weeks to
6 months.
Inability to perform normal voluntary saccades was
confined to horizontal pursuit, vertical OMA was not
observed in any of our patients. In almost all subjects
OMA gradually ameliorated over the years, with
complete cessation in two siblings (#8 and #9) at age 4
and 5 years. Additional oculomotor features comprised
nystagmus in three patients and Duane syndrome in two
siblings (#8 and #9).
Neurological features and developmental course
In most patients, early-onset cerebellar ataxia together
with muscular hypotonia constituted further clinical
hallmarks with gradual amelioration during the first dec-
ade, while general clumsiness persisted. Motor develop-
ment was delayed in most cases, unsupported walking
was achieved at ages ranging from 14 months to four
years (mean 25 months). All subjects showed gradual
ongoing improvement of motor skills. Development of
both, language perception and expressive speech was
delayed as well in all but two cases. An impairment of
cognitive development was observed in 11 cases com-
prising learning disability (IQ 70-84; n = 7) or intellectual
disability (IQ <70; n = 4).
Neuroimaging features
Systematic analysis of all MRI data sets revealed a MTS
in 11 patients, indicating JBTS (Fig. 1). Among these pa-
tients with MTS, 10 additionally had vermian hypo-/dys-
plasia, predominantly of the superior part of the vermis
cerebelli, and one of these cases showed agenesis of the
corpus callosum. In one patient with MTS, MRI was
otherwise normal. In one male patient (#7) cerebellar
dysplasia, cerebellar cysts, and enlargement as well as
square shape of the 4th ventricle clearly pointed to
Poretti-Boltshauser syndrome [20, 21]. One patient had
dysmorphic basal ganglia, abnormal shape of frontal
horns, abnormal corpus callosum, reduced pontine
prominence, and enlarged ventricles, suspicious of a
tubulinopathy [22]. In 4 cases MRI revealed vermian
hypo-/dysplasia as sole abnormality. MRI was normal in
the remaining 4 patients (Fig. 2).
Comparison of clinical phenotypes of COMA vs. JBTS
A comparison of qualitative clinical features and quanti-
tative developmental data revealed no difference be-
tween the subgroup of patients with inconclusive MRI
vs. those with MTS on MRI concerning present age, age
at diagnosis of COMA, and amelioration of OMA
(Table 2). Unsupported walking was attained at slightly
higher ages in children with JBTS, and there was a
strong trend to more severe cognitive impairment in
JBTS. However, these differences did not reach statistical
significance, possibly due to small case numbers.
Various features
A 17-year-old boy with MTS (# 4) had retinal coloboma,
neonatal breathing dysregulation, and persistently elevated
liver enzymes. These features are well-known in JBTS with
liver involvement due to TMEM67 mutations [23], but
had not been recognized earlier as pointing to JBTS in our
patient. Patient # 15 with MTS had congenital clubfoot,
which was occasionally reported in JBTS, namely in a 4-
year-old girl with a homozygous frameshift mutation in
the RPGRIP1L gene [24]. No other clinical or laboratory
features of JBTS, including polydactyly, facial dysmorph-
ism, neonatal breathing dysregulation, skeletal dysplasia,
cystic dysplastic kidneys, liver fibrosis, midline oral or fa-
cial defects, and oral soft tumors were observed in any of
the remaining 9 patients with MTS.
Discussion
In our cohort of 21 patients with clinical phenotypes
consistent with COMA a reappraisal of MR images
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Table 1 Clinical and neuroradiological features of 21 patients with "congenital ocular motor apraxia type Cogan" (COMA)
Patient #
(origin)
Sex Current age
(years)
Affected/
unaffected
siblings
Development Neurological findings MRI features Diagnostic
assignment
Unaided
walking at
age (months)
Speech
delay
Ocular apraxia [age at
onset (months)/course/age
at disappearance]
Early
onset
ataxia
Cognitive
development
Seizures
1 (A) f 4 0/1 18 Yes 3/↓/- Yes Learning disability No MTS, vermian hypo-/dysplasia JBTS
2 (D) m 7 0/0 27 Yes 8/↓/- Yes Learning disability No MTS, superior vermian hypoplasia,
slightly enlarged external csf spaces
JBTS
3 (D) f 12 0 / 1 20 No 3/↓/- No Normal No Normal COMA
4 (D) m 18 0/1 30 Yes 3/↓/- Yes Learning disability No MTS, superior vermian dysplasia JBTS
5 (TR) f 5 0/2 30 Yes 4/↓/- Yes Intellectual disability No MTS, superior vermian hypo-/dysplasia JBTS
6 (D) f 4 0/1 27 No 6/↓/- Yes Normal Yes vermian dysplasia, otherwise normal COMA
7 (TR) m 18 0/1 20 Yes 6/↔/- Yes Normal No Cerebellar cysts, cerebellar hypoplasia,
square 4th ventricle
Poretti-Boltshauser
syndrome
8 (D) m 24 1 (#9)/1 24 Yes 6/↓/4 years Yes Intellectual disability No MTS, vermian hypo-/dysplasia JBTS
9 (D) f 21 1 (#8)/1 14 Yes 11/↓/5 years Yes Learning disability No MTS, otherwise normal JBTS
10 (T) m 9 0/3 24 Yes 6/↓/- Yes Learning disability Yes Inferior vermian dysplasia, large cerebellum,
slight caudal extension of cerebellar tonsils
COMA
11 (D) m 16 0/3a 27 Yes 2/↓/- No Normal No Normal COMA
12 (D) f 6 0/0 20 Yes 10/↓/- Yes Normal No Normal COMA
13 (D/UK) m 2 0/2a 27 No 8/↓/- Yes Normal No MTS, otherwise normal (mild superior
vermian hypo-/dysplasia??)
JBTS
14 (CH) m 7 0/1 24 Yes 6/↓/- Yes Normal No mild vermian dysplasia, otherwise normal COMA
15 (D) m 6 0/2 30 Yes 8/↓/- Yes Intellectual disability No MTS, superior vermian dysplasia JBTS
16 (D) m 22 1 (#17)/1 30 Yes 6/↓/- Yes Normal Yes MTS, vermian hypo-/dysplasia JBTS
17 (D) m 17 1 (#16)/1 42 Yes 3/↓/- Yes Low normal No MTS, superior vermian hypo-/dysplasia JBTS
18 (D) f 23 0/1 24 No 4/↓/- Yes Learning disability No Normal COMA
19 (D) f 6 0/1 + 1a 14 No 6/↓/- No Normal No Superior vermian dysplasia, otherwise normal COMA
20 (R/K) m 10 0/1 + 1a 48 Yes 5/↓/- Yes Intellectual disability No Enlarged ventricles, dysmorphic basal
ganglia, hypoplastic corpus callosum,
abnormal proportions of brain stem
Brain malformation
suspicious of
tubulinopathy
21 (D) m 6 0/1 36 Yes 8/↓/- Yes Learning disability No MTS, callosal agenesis, vermian hypo-/
dysplasia, hippocampal malrotation,
dysplastic tectal plate
JBTS
Abbreviations: A Albanian origin, CH Swiss origin, D German origin, K Kazakh origin, R Russian origin, T Turkish origin, UK British origin, m male, f female, ↓ attenuating, ↔ unchanged, MTS molar tooth sign, JBTS Joubert
syndrome, a half-siblings
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primarily judged to be normal revealed a MTS in 11 pa-
tients. Thus the majority of patients clinically diagnosed
to have COMA can in fact be assigned to JBTS. All these
MR images had previously been analyzed by board-
certified radiologists or neuroradiologists, in some cases
with explicit question whether there is a MTS, and had
been rated as normal.
Several factors contribute to the difficulties in recogni-
tion of the MTS in our cohort: The molar tooth is a
characteristic, but subtle MRI sign which is easily
missed. It was recognized as a typical hallmark of JBTS
in neuroimaging only in 1997, 28 years after first de-
scription of JBTS as a clinical syndrome [16]. MRI was
introduced in clinical neurology in the mid-1980s. Ac-
cording to a medline search seven articles dealing with
JBTS and MRI were published in scientific journals from
1989 until 1997 without perceiving the MTS. In two sib-
lings (#8 and #9) of our cohort the first MRI was per-
formed before 1997. Finally, technical shortcomings of
the MRI investigation including inadequate angulation
or slice thickness may additionally hamper recognition
of the MTS.
In two additional patients of our cohort re-evaluation
of MRI revealed otherwise specific neuroimaging fea-
tures. An 18-year-old man (#7) with clinical phenotype
consistent with COMA had clear MRI characteristics of
Poretti-Boltshauser syndrome, and a 10-year-old boy
showed neuroimaging features pointing to a tubulinopa-
thy. Appropriate molecular genetic investigations are
under way in these two cases. In the remaining 8 pa-
tients with clinical phenotype consistent with COMA
MRI revealed no conclusive findings.
These results strongly underline that a brain MRI of a
child with COMA needs to be reviewed by a neuroradi-
ologist or neurologist with experience in pediatric pos-
terior fossa diseases, particularly malformations. As has
been shown for brain MRI in children with cerebral
Fig. 1 Molar tooth sign on MRI of an infant with Joubert syndrome. a, b Sagittal T1-weighted and c-d axial T2-weighted MRI of patient #1 at age
8 months. a Midsagittal slice shows vermian hypo-/dysplasia (arrows), rostral shifting of the fastigium (star), and deep interpeduncular fossa
(arrowhead). b Parasagittal slice displays thickened and horizontalized superior cerebellar peduncles (SCP)(arrow). c-e Axial slices show deep inter-
peduncular fossa (arrowhead) and elongated SCP (arrows), resulting in “molar tooth sign”, and irregular folia of upper vermis (circle). These MRI
features indicate Joubert syndrome
Fig. 2 Normal MRI in a 19-year-old patient with COMA. a, b Sagittal
and (c) axial T2-weighted MRI of patient #18 at age 19 years.
a Midsagittal slice shows normal position of fastigium (star) and
well developed vermis. b Parasagittal slice displays thin superior
cerebellar peduncles (SCP) in oblique position (arrow). c Axial slice
shows normal SCP (arrow). This MRI is normal
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palsy the accuracy of neuroimaging reports clearly de-
pends on the expertise of those reporting [25]. An expert
review is even more important in a child with COMA
and abnormal cognitive function, as the chance of a
MTS is much higher in this subgroup of children with
COMA (73 % vs. 25 % in our cohort).
Among the four patients originally described by Cogan
in 1952, no other neurologic symptoms were present in
two, while one had convulsions shortly after birth with-
out neurologic sequelae and one had a persistent extra-
pyramidal disorder assigned to intrauterine carbon
monoxide poisoning [1]. The follow-up report of these 4
patients 14 years later stated difficulties in reading (due
to OMA) and normal intelligence in three patients, with
additional mild balance problems in one of them. The
patient with carbon monoxide poisoning had spasticity,
ataxia and borderline intellectual disability [26]. It is ob-
vious from these clinical depictions that in his original
report Cogan did not delineate a homogeneous clinical
entity but rather described a clinical sign observed in a
small heterogeneous group of patients. Once OMA was
recognized by neurologists and ophthalmologists the
relatively frequent co-occurrence of infantile-onset
OMA (COMA) in sporadic and familial cases with early-
onset ataxia and delay of psychomotor development
resulted in the perception of COMA as an entity, namely
a complex neurodevelopmental disorder with autosomal-
recessive inheritance.
It has been doubted “whether Cogan-type oculomotor
apraxia can exist as an isolated entity” [27], and a
current concept assigns COMA to three main clinical
conditions [28]: “a. In the “benign” or “idiopathic” variety
of congenital ocular motor apraxia, neuroimaging is nor-
mal and there is no readily identifiable explanation for
the disorder. Although the neurologic examination and
intellect are usually normal, occasionally associated
neurologic defects include hypotonia, motor and speech
delay, and ataxia…b. Some patients with congenital ocu-
lar motor apraxia have a nonprogressive, noninherited
structural abnormality of the brain, caused either by a
developmental anomaly or by prenatal or perinatal insult.
These include: dysgenesis of the cerebellar vermis or cor-
pus callosum, inferior vermian hypoplasia, Dandy–Walker
malformation, gray matter heterotopias, and perinatal is-
chemia. c. A variety of genetic disorders with multisystem
involvement may present in infancy with congenital ocular
motor apraxia. These include Joubert syndrome, Jeune
syndrome (nephronophthisis, asphyxiating thoracic dys-
trophy, retinal degeneration, and ataxia), and a subset of
patients with Leber congenital amaurosis, a retinal dys-
trophy.” [28] Poretti-Boltshauser syndrome and tubulino-
pathies are to be added to this list of genetic disorders.
JBTS, Jeune syndrome, and Leber congenital amaurosis
are all ciliopathies and most likely overlapping phenotypes
of the same group of diseases.
In contrast to this spectrum of conditions related to
COMA, acquired OMA especially occurs in a range of
different genetic disorders comprising ataxia teleangiec-
tasia (AT), ataxia with ocular motor apraxia 1 (AOA1),
and ataxia with ocular motor apraxia 2 (AOA2). The as-
sociated genes ATM (AT), aprataxin (AOA1) and sena-
taxin (AOA2) are involved in mechanisms of DNA
repair.
Conclusions
Our results indicate that a large subgroup of patients di-
agnosed with “benign” or “idiopathic” COMA in fact
have JBTS, as the MTS was missed on MRI – which
may easily happen. Therefore meticulous analysis of the
MRI in patients with COMA is advisable. Furthermore
we found no consistent differences in clinical pheno-
types (developmental delay, intellectual impairment,
ataxia) between patients with the MTS and those with
“benign” or “idiopathic” COMA, apart from one case
with Poretti-Boltshauser syndrome and one patient with
clinical features pointing to JBTS which were however
not previously recognized in their diagnostic value in
these patients.
Table 2 Comparison of clinical features in patients with Joubert syndrome vs. those with inconclusive MRI findings
Neuroradiological diagnosis Joubert syndrome Inconclusive MRI T p
Number of patients 11 8
Sex 8 male, 3 female 3 male, 5 female
Present age (years) [mean (SD)] 12.0 (8.3) 10.4 (6.4) 0.46 0.65
Age at diagnosis of COMA (months) [mean (SD)] 6.2 (2.7) 5.4 (2.4) 0.67 0.51
Amelioration of OMA 100 % (11/11) 100 % (8/8)
Unsupported walking at age (months) [mean (SD)] 28.0 (7.7) 22.5 (4.3) 1.82 0.09
Cognitive development: Fisher´s exact test: p = 0.055
Normal 3 6
Learning disability or intellectual disability 8 2
Abbreviations: COMA congenital ocular motor apraxia, OMA ocular motor apraxia, SD standard deviation, T T value from T-test for independent variables
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In the future, delineation of new clinical and genetic
entities associated with early-onset OMA will possibly
allow for assignment of hitherto ill-defined cases of
“idiopathic” COMA to a specific diagnosis. Additional
genetic studies using whole exome sequencing are
needed to clarify whether a subset of cases with early-
onset OMA without the MTS on MRI frames a noso-
logical entity with a distinct genetic basis and autosomal
recessive inheritance, possibly constituting a further part
of the clinical and genetic spectrum of ciliopathies.
Additional file
Additional file 1: Congenital Ocular Motor Apraxia (COMA) –
Questionnaire. (DOCX 26 kb)
Abbreviations
AOA1, ataxia with ocular motor apraxia 1; AOA2, ataxia with ocular motor
apraxia 2; AT, ataxia teleangiectasia (AT); COMA, congenital ocular motor
apraxia; JBTS, Joubert syndrome; MTS, molar tooth sign; OMA, ocular motor
apraxia
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